Government · 2 deals
Every published round U.S. Government took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Silicon Quantum Computing | Accelerator | 2025 | - | Participant | SmartCompany | |
| Ellume Health | Grant | 2 Feb 2021 | $300m | Lead | Startup Daily (Tue 20 Jun 2023), @AuManufacturing, SmartCompany (Tue 6 Jul 2021), SmartCompany (Tue 2 Feb 2021), Startup Daily (Tue 2 Feb 2021) |
Companies U.S. Government has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ellume Health | 2 Feb 2021, Grant | 1 | 1 | |
| Silicon Quantum Computing | 2025, Accelerator | 1 | 0 |
Fund closes reported for U.S. Government, as distinct from the investments it has made.
Companies U.S. Government has backed that another company then bought. An exit for the holding, not a deal U.S. Government did.
| Name | Role | Sources |
|---|---|---|
| Howard Lutnick | Commerce Secretary | Startup Daily |
Stories naming U.S. Government. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Melbourne-based ENA Respiratory announced US patent allowances covering its TLR2 agonist platform and a COPD treatment method, strengthening IP protection for its INNA-051 nasal spray candidate now in Phase II testing.
The National Reconstruction Fund has put $20 million into Sydney quantum chip maker Silicon Quantum Computing via a SAFE note, following its smaller-than-planned 2023 Series A and a similar NRF bet on Diraq.
Melbourne biotech ENA Respiratory has begun dosing volunteers in a mid-stage trial of its INNA-051 antiviral spray, aimed at limiting common viral illnesses in at-risk groups.
Climate Salad's report says Australia's climate tech sector has passed 7,000 workers across 730 startups and drew $680 million in venture capital; Sea Forest's ASX debut and fund commitments point to investor appetite.
Vaxxas announced a roughly A$90m financing — Series D equity led by SPRIM Global Investments plus debt — to advance its needle-free vaccine patch, alongside leadership changes including a new chair.
A news roundup covering a government-backed hydrogen project for Telstra, a climate tech fund's first close, new appointments at a South Australian agency and a feed company, plus export approvals and science prizes.
Also @AuManufacturing
Interview with Stoic Venture Capital's Guy Hedley, Craig Swanger and Geoff Waring on backing university science startups, their Uniseed partnership, a planned 2024 All Stars Fund II, and new analyst Safaa Nasrallah.
Queensland's Advance Queensland initiative has granted more than $5.5 million to 56 small businesses across two programs, with Rainstick and Carbonaught among recipients; Carbonaught also recently won a US government grant.
A First Nations-led angel network launched in Perth with $500,000 already committed to its fund, ten founding investors named, and backing from the US consulate and Minderoo's Generation One.
DroneShield and Epirus have combined DroneShield's DroneSentry detection system with Epirus's Leonidas microwave weapon. The piece also recalls Epirus's earlier investment in DroneShield and recent DroneShield order wins.
Wholesale Investor profiles Cityzenith, a US digital twin platform, highlighting its World Economic Forum recognition, a Regulation A+ offering nearing $4 million of a $15 million target, rising share price, and city contracts.